Live Breaking News & Updates on Cutaneous Oncology

Stay updated with breaking news from Cutaneous oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

When Does the PD-1 Inhibitor Come Before the Hedgehog Inhibitor for Neoadjuvant BCC/CSCC?

Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers. ....

Boston , Massachusetts , United-states , Washington , France , Stanford , California , Florida , Texas , Houston , University-of-california-san-francisco , Vishala-patel